TimeScale Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

TimeScale Financial’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$10.6K	Hold	30	–	–	﹤0.01%	356
2023 Q1	$9.45K	Hold	30	–	–	﹤0.01%	355
2022 Q4	$8.69K	Hold	30	–	–	﹤0.01%	315
2022 Q3	$9K	Hold	30	–	–	﹤0.01%	311
2022 Q2	$8K	Hold	30	–	–	﹤0.01%	321
2022 Q1	$8K	Hold	30	–	–	﹤0.01%	338
2021 Q4	$7K	Hold	30	–	–	﹤0.01%	352
2021 Q3	$5K	Hold	30	–	–	﹤0.01%	381
2021 Q2	$6K	Hold	30	–	–	﹤0.01%	369
2021 Q1	$6K	Hold	30	–	–	﹤0.01%	371
2020 Q4	$7K	Buy	30 +22	+275%	+$5.05K	﹤0.01%	318
2020 Q3	$2K	Hold	8	–	–	﹤0.01%	406
2020 Q2	$2K	Hold	8	–	–	﹤0.01%	402
2020 Q1	$1K	Hold	8	–	–	﹤0.01%	399
2019 Q4	$1K	Hold	8	–	–	﹤0.01%	498
2019 Q3	$1K	Hold	8	–	–	﹤0.01%	481
2019 Q2	$1K	Buy	+8	New	+$1.4K	﹤0.01%	499

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TimeScale Financial's VRTX Position: Q2 2023 in Review

TimeScale Financial held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2023 at 30 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

TimeScale Financial first reported a position in VRTX in Q2 2019 and has held it in 17 quarters since. 1,285 funds tracked by Wall St. Rank hold VRTX as of Q2 2023.

TimeScale Financial held 30 shares of Vertex Pharmaceuticals worth $10.6K as of Q2 2023.
TimeScale Financial left its Vertex Pharmaceuticals share count unchanged in Q2 2023.
Vertex Pharmaceuticals made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #356 holding.
TimeScale Financial first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 17 quarters since.
1,285 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.